Pelthos Therapeutics (PTHS) Inventory Average (2025 - 2026)
Pelthos Therapeutics (PTHS) posted Inventory Average of $22.4 million for Q2 2026, down 4.47% on a QoQ basis from $23.5 million in Q1 2026.
Analysis
Pelthos Therapeutics (PTHS) Inventory Average (2025 - 2026) Analysis & Trends
Pelthos Therapeutics has reported Inventory Average for 2 years, with the latest figure at $22.4 million in Q2 2026.
- On a quarterly basis, Inventory Average changed N/A year-over-year to $22.4 million in Q2 2026; TTM through Jun 2026 was $22.4 million, a N/A change from a year earlier, with the FY2026 full-year figure at $22.5 million, changed N/A from the prior year.
- Inventory Average was $22.4 million for Q2 2026 at Pelthos Therapeutics, down from $23.5 million in the prior quarter.
- The five-year high for Inventory Average was $23.8 million in Q4 2025, with the low at $22.4 million in Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.22 Bn | 620.47 Bn | 17.26 Bn | 14.86 Bn |
| 2 | AbbVie | 446.22 Bn | 439.65 Bn | 12.70 Bn | 5.09 Bn |
| 3 | Merck | 357.04 Bn | 349.90 Bn | 12.21 Bn | 6.34 Bn |
| 4 | Novartis Ag | 268.38 Bn | 260.69 Bn | 11.24 Bn | 6.25 Bn |
| 5 | Pfizer | 156.32 Bn | 144.62 Bn | 10.94 Bn | 10.31 Bn |
| 6 | Sanofi | 52.23 Bn | 44.85 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 43.18 Bn | 43.18 Bn | - | - |
| 8 | Incyte | 24.85 Bn | 20.31 Bn | 1.57 Bn | 114.08 Mn |
| 9 | United Therapeutics | 21.29 Bn | 18.62 Bn | 683.80 Mn | 186.05 Mn |
| 10 | Pelthos Therapeutics | 80.38 Mn | 55.82 Mn | 21.23 Mn | 22.45 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 22.45 Mn |
| Mar 31, 2026 | 23.50 Mn |
| Dec 31, 2025 | 23.84 Mn |